10.2% Above Target

BPRN's consensus price target is $34, -10.2% below the current price of $37.87. The 6 analysts tracking BPRN see downside risk at present valuations.

BPRN has a consensus rating of "Buy" based on 6 Wall Street analysts. The rating breakdown is mixed, with 3 Hold ratings making up the largest segment. The consensus 12-month price target of $34 implies -10.2% downside from current levels.

With a forward P/E of 10.4293x, BPRN trades at a relatively low valuation. The consensus target of $34 implies -10.2% move, suggesting the market may be pricing in risks.

The most bullish Wall Street analyst has a price target of $34 for BPRN, while the most conservative target is $34. The consensus of $34 represents the median expectation. Our quantitative valuation model projects a bull case target of $63 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

BPRN is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month BPRN stock forecast based on 6 Wall Street analysts shows a consensus price target of $34, with estimates ranging from $34 (bear case) to $34 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $48, with bear/bull scenarios of $30/$63.

Our quantitative valuation model calculates BPRN's fair value at $48 (base case), with a bear case of $30 and bull case of $63. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.

BPRN trades at a forward P/E ratio of 10.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 14.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Analysts are cautious on BPRN, with 0 Sell ratings and a price target of $34 (-10.2% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

BPRN analyst price targets range from $34 to $34, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $34 consensus represents the middle ground. Our model's $30-$63 range provides an independent fundamental perspective.